Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Post by AjarnEvanon Apr 21, 2023 1:56am
179 Views
Post# 35406611

MDMA: You couldn't have gotten luckier

MDMA: You couldn't have gotten luckierThere is a treasure trove of information available for perceptive investors. Do your best not to be turned off by the short sellers who make their living day to day and believe that low effort posts and comments influence the market. Let them play with each other and scalp a few shares here and there.

The most important aspect of holding shares in PharmAla presently is that you understand what the company behind the ticker is doing: making new supply deals and delivering, making manufacturing deals, and the all important networking such as at the most recent Benzinga conference. Business is moving forward and revenue is being generated. There are many catalysts upcoming which would be excellent proft taking times but the timeline is long.

Try not to get to caught up in that nonsense about cash position - this is a junior company and it has just become the #1 company in the space. Lots of people make their living working to seperate retail investors from their money and there's no better defense than to ignore ignore ignore.

See you on the moon.
<< Previous
Bullboard Posts
Next >>